Problem Overview Biological drugs are currently the leading treatment for many chronic diseases, but they create a significant financial and medical burden on healthcare systems.
Key Points
1. Extremely High Cost Biological treatments can cost tens of thousands of dollars per patient per year. The market has already reached hundreds of billions of dollars and is expected to approach $1 trillion within the next decade. This cost is not sustainable for healthcare systems and insurers.
2. Medical Risk (Immune System Suppression) These drugs act on the immune system, which leads to:
Increased risk of infections
Requirement for continuous monitoring and testing
Limited suitability for certain patients
3. Ongoing Treatment, Not a Cure Biological drugs:
Do not cure the disease
Require continuous, long-term use
Symptoms often return when treatment stops
4, Dependence on Healthcare Infrastructure Treatment requires:
Specialist physicians
Regular blood tests
In some cases, clinic visits for infusions
This creates a burden on both patients and healthcare providers.
5. Uncertain Patient Response Not all patients respond to treatment, and in some cases effectiveness declines over time. Patients may need to switch between multiple expensive therapies.
Bridge to Your Solution
There is a clear need for a solution that is:
Safer
Significantly lower cost
Non-immunosuppressive
Accessible at scale
This is where our phototherapy technology provides a compelling alternative—delivering an effective, FDA-approved, and cost-efficient solution with the potential to significantly reduce healthcare spending.
Strong Closing
The shift from high-cost biological drugs to physical therapies like phototherapy is not only a business opportunity—it is a necessary evolution in global healthcare.
We are seeking investment to open clinics in additional countries, building on our clinics in Israel, which have delivered 250,000 treatments.
Our clinics provide a much lower-cost alternative to biological medications, which place a heavy burden on the healthcare economy and are expected to reach $1 trillion within 10 years.
